Question 1

Does PanAgora Asset Management own CLDX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, PanAgora Asset Management holds 572,538 shares of CLDX (Celldex Therapeutics), worth $21.3M.

Question 2

How many shares of CLDX does PanAgora Asset Management own?

Accepted Answer

As of its Q2 2026 13F, PanAgora Asset Management holds 572,538 shares of CLDX (Celldex Therapeutics).

Question 3

What is PanAgora Asset Management's CLDX position worth?

Accepted Answer

As of its Q2 2026 13F, PanAgora Asset Management's CLDX position is worth $21.3M.

Question 4

Is PanAgora Asset Management buying or selling CLDX?

Accepted Answer

In Q2 2026, PanAgora Asset Management increased its CLDX position from 142,327 to 572,538 shares.

Question 5

When did PanAgora Asset Management first buy CLDX?

Accepted Answer

PanAgora Asset Management already held CLDX in its Q4 2018 13F, the earliest on record, and has listed it in 20 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	572,538	+302.3%	$21.3M	0.1%	$37.21	46
2026-Q1	Increased	142,327	+551.2%	$4.5M	0.0%	$31.72	43
2025-Q4	Increased	21,856	+7.5%	$593,609	0.0%	$27.16	26
2025-Q3	Unchanged	20,334	0.0%	$526,041	0.0%	$25.87	0
2025-Q2	Decreased	20,334	-0.6%	$413,797	0.0%	$20.35	0
2025-Q1	Decreased	20,453	-82.3%	$371,222	0.0%	$18.15	0
2024-Q4	Decreased	115,633	-0.9%	$2.9M	0.0%	$25.27	0
2024-Q3	Decreased	116,674	-1.4%	$4M	0.0%	$33.99	0